DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab (DYNAMIC)

Clinical Trial ID NCT04954339

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04954339

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatocellular carcinoma. N Engl J Med 2011 19.40
2 Hepatocellular carcinoma. Lancet 2012 18.09
3 Aasld guidelines for the treatment of hepatocellular carcinoma. Hepatology 2017 0.83
Next 100